Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v1-EN
Language English English
Date Updated 2017-05-30 2017-03-11
Drug Identification Number 02282127 02282127
Brand name APO-RISPERIDONE APO-RISPERIDONE
Common or Proper name RISPERIDONE RISPERIDONE
Company Name APOTEX INC APOTEX INC
Ingredients RISPERIDONE RISPERIDONE
Strength(s) 0.50MG 0.50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL 500 BTL
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10 2017-03-10
Estimated end date 2017-06-02 2017-05-24
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments APO-RISPERIDONE FCT 0.5MG 100 BTL is available
Health Canada comments